Tag: CRSP stock

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.83 million

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.67 million

In a filing, CRISPR Therapeutics AG revealed its General Counsel and Secretary KASINGER JAMES R. unloaded Company’s shares for reported